Column Group
Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RAPT, ORIC, TNYA, NGM, Surrozen, and represent 100.00% of Column Group's stock portfolio.
- Reduced shares in these 3 stocks: Surrozen (-$83M), RVMD (-$35M), Effector Therapeutics.
- Sold out of its position in Effector Therapeutics.
- Column Group was a net seller of stock by $-120M.
- Column Group has $151M in assets under management (AUM), dropping by 0.51%.
- Central Index Key (CIK): 0001833486
Tip: Access up to 7 years of quarterly data
Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Column Group
Column Group holds 6 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rapt Therapeutics (RAPT) | 44.0 | $67M | 2.7M | 24.85 |
|
|
| Oric Pharmaceuticals (ORIC) | 21.7 | $33M | 3.6M | 9.20 |
|
|
| Tenaya Therapeutics (TNYA) | 20.1 | $31M | 9.4M | 3.24 |
|
|
| Ngm Biopharmaceuticals (NGM) | 10.3 | $16M | 18M | 0.86 |
|
|
| Surrozen | 3.9 | $5.9M | -93% | 628k | 9.40 |
|
| Revolution Medicines (RVMD) | 0.0 | $1.3k | -99% | 46.00 | 28.67 |
|
Past Filings by Column Group
SEC 13F filings are viewable for Column Group going back to 2020
- Column Group 2023 Q4 filed Feb. 9, 2024
- Column Group 2023 Q3 filed Nov. 13, 2023
- Column Group 2023 Q2 filed July 24, 2023
- Column Group 2023 Q1 filed May 15, 2023
- Column Group 2022 Q4 filed Feb. 13, 2023
- Column Group 2022 Q3 filed Nov. 14, 2022
- Column Group 2022 Q2 filed Aug. 12, 2022
- Column Group 2022 Q1 filed May 16, 2022
- Column Group 2021 Q4 filed Feb. 11, 2022
- Column Group 2021 Q3 filed Nov. 12, 2021
- Column Group 2021 Q2 filed Aug. 16, 2021
- Column Group 2021 Q1 filed May 17, 2021
- Column Group 2020 Q4 filed Feb. 16, 2021